LIVAGEN 20mg

for: Liver Support & Detox Aid.

Livagen (20mg) is a specialized research bioregulator utilized primarily to investigate epigenetic modulation and the decondensation of chromatin in aging cells. As a synthetic short-chain peptide, it is a potent activator of ribosomal genes and a key regulator of cellular longevity. Dragon Pharma provides Livagen 20mg at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of peptide-based bioregulation and anti-aging science, Livagen has emerged as a fundamental tool for investigators exploring the reversal of cellular senescence. Known scientifically as a biomimetic peptide related to Epithalon, this compound has become a primary instrument for researchers studying the "unlocking" of the genetic material within the cell nucleus. Dragon Pharma provides Livagen 20mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Peptide capable of producing reproducible and accurate data in complex geriatric and genomic models.

As scientific inquiry into neurodegeneration, cardiovascular resilience, and immune system rejuvenation expands, the need for reliable chromatin-remodeling peptides like Livagen has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of Livagen 20mg.

Molecular Characteristics and Chemical Profile

The structural integrity of Livagen is defined by its simple, three-amino acid sequence. Its small molecular weight allows it to bypass cellular barriers and enter the nucleus, where it directly interacts with DNA-protein complexes.

• Chemical Identity: Livagen (Lys-Glu-Asp-Ala / Lys-Glu-Asp)
• Molecular Formula: C₁₈H₃₁N₅O₉
• Molecular Weight: 461.47 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Lyophilized powder
• Manufacturer: Dragon Pharma

Source: PubChem

Research Applications

The peptide is utilized in various scientific investigative domains, including:

• Epigenetic Modeling: Mapping the decondensation of pericentromeric heterochromatin in elderly cell lines.
• Immune Rejuvenation: Investigating the reactivation of ribosomal genes in lymphocytes of geriatric models.
• Cardiovascular Biology: Studying the modulation of vascular wall integrity and blood pressure regulation.
• Neuroprotection: Assessing the reduction of age-related cognitive decline through gene expression.
• Gastrointestinal Research: Evaluating the repair of the intestinal mucosa in metabolic strain models.

Pathway and Mechanistic Context

The core value of Livagen 20mg in a laboratory setting is its ability to manipulate the chromatin structure without changing the actual DNA sequence. In a natural aging state, chromatin tends to become "clumped" or condensed, effectively silencing important genes. Livagen bypasses this suppression by promoting the unraveling of these genetic sites.

Source: NIH

The Chromatin-Ribosomal Axis

Upon activation by Livagen, cells demonstrate a marked increase in the activity of ribosomal genes. This facilitates a global shift in cellular behavior, promoting protein synthesis and repairing the damage associated with chronological aging.

Key Mechanistic Shifts:

• Gene Reactivation: Livagen leads to the re-expression of genes that were previously silenced due to age-related heterochromatin formation.
• Metabolic Stabilization: It promotes a shift toward energy-producing pathways by optimizing the cellular "software" at the genetic level.
• Protein Synthesis: By increasing ribosomal activity, it enhances the cell's capacity to build and repair structural proteins.

Primary Research Applications

1. Gerontology and Longevity Research

Livagen is heavily utilized in studies involving cellular lifespan. Because it addresses the epigenetic "noise" that accumulates over time, it provides a unique framework for investigating how to restore youthful function to aged tissues in animal models.

2. Immunological Rejuvenation Studies

Known in research circles as a potent immune booster, Livagen is used to observe how leukocytes adapt to perceive a younger physiological state. Investigators study the restoration of interferon production and the reversal of immune senescence.

3. Cardiovascular Wall Integrity

In vascular research models, Livagen is studied for its ability to regulate the structural components of the vessel walls. Research models focusing on hypertension and atherosclerosis examine how Livagen engages pathways that maintain vascular elasticity.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. Livagen 20mg is produced under strict laboratory conditions to ensure that the compound remains stable and bioactive.

• Lyophilization for Stability: The compound is supplied in a lyophilized (freeze-dried) form. This process removes moisture while preserving the molecular structure, ensuring it arrives at your facility in optimal condition.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the chemical signature matches the intended Livagen profile.

Product Usage Disclaimer: This product is intended for laboratory and in-vitro research use only. It is not approved for human or veterinary application. Must be handled by qualified professionals. Not for drug, food, or cosmetic purposes. Misuse or misbranding is strictly prohibited.